Evidence map›Paper›PMID 10521303›Full record

ArticleAmerican journal of human genetics1999

Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.

R W Burman, P A Yates, L D Green, P B Jacky, M S Turker, B W Popovich

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. The structure of theThe Journal of biological chemistry · 2020
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

R W BurmanDepartment of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, OR, USA.
P A Yates
L D Green
P B Jacky
M S Turker
B W Popovich
Oregon Health & Science University · USKaiser Permanente · US

Funding

MOLECULAR GENETIC BASIS OF HUMAN DISEASET32GM008617 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LISKAY, ROBERT MICHAEL · 1997 to 2006
$869k
NIGMS NIH HHS T32 GM008617NIGMS NIH HHS T32 GM08617
6 · The paper itself

Abstract

The vast majority of fragile-X full mutations are heavily methylated throughout the expanded CGG repeat and the surrounding CpG island. Hypermethylation initiates and/or stabilizes transcriptional inactivation of the FMR1 gene, which causes the fragile X-syndrome phenotype characterized, primarily, by mental retardation. The relation between repeat expansion and hypermethylation is not well understood nor is it absolute, as demonstrated by the identification of nonretarded males who carry hypomethylated full mutations. To better characterize the methylation pattern in a patient who carries a hypomethylated full mutation of approximately 60-700 repeats, we have evaluated methylation with the McrBC endonuclease, which allows analysis of numerous sites in the FMR1 CpG island, including those located within the CGG repeat. We report that the expanded-repeat region is completely free of methylation in this full-mutation male. Significantly, this lack of methylation appears to be specific to the expanded FMR1 CGG-repeat region, because various linked and unlinked repetitive-element loci are methylated normally. This finding demonstrates that the lack of methylation in the expanded CGG-repeat region is not associated with a global defect in methylation of highly repeated DNA sequences. We also report that de novo methylation of the expanded CGG-repeat region does not occur when it is moved via microcell-mediated chromosome transfer into a de novo methylation-competent mouse embryonal carcinoma cell line.

Indexed as

DNA MethylationRNA-Binding ProteinsAdultAllelesAlu ElementsAnimalsCells, CulturedCpG IslandsDeoxyribonucleases, Type II Site-SpecificDNA Restriction EnzymesFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansMaleMiceNerve Tissue ProteinsDeoxyribonucleases, Type II Site-SpecificDNA Restriction Enzymesendodeoxyribonuclease XmaIIIFMR1 protein, humanFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1McrBC endonucleaseNerve Tissue ProteinsRNA-Binding Proteins

Identifiers

PMID10521303
PMCPMC1288290
OpenAlexW2035193321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.